443 related articles for article (PubMed ID: 34326372)
21. LncRNA WT1-AS Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Downregulating Transforming Growth Factor β1.
Wang J; Xi C; Yang X; Lu X; Yu K; Zhang Y; Gao R
Cancer Biother Radiopharm; 2019 Dec; 34(10):671-675. PubMed ID: 31621381
[No Abstract] [Full Text] [Related]
22. Identification of Hub Genes and Upstream Regulatory Factors Based on Cell Adhesion in Triple-negative Breast Cancer by Integrated Bioinformatical Analysis.
Han YH; Wang Y; Lee SJ; Mao YY; Jiang P; Sun HN; Jin MH; Kwon T
Anticancer Res; 2023 Jul; 43(7):2951-2964. PubMed ID: 37351977
[TBL] [Abstract][Full Text] [Related]
23. LncRNA OTUD6B-AS1 promotes paclitaxel resistance in triple negative breast cancer by regulation of miR-26a-5p/MTDH pathway-mediated autophagy and genomic instability.
Li PP; Li RG; Huang YQ; Lu JP; Zhang WJ; Wang ZY
Aging (Albany NY); 2021 Nov; 13(21):24171-24191. PubMed ID: 34740994
[TBL] [Abstract][Full Text] [Related]
24. Identification of Potential Long Non-Coding RNA Candidates that Contribute to Triple-Negative Breast Cancer in Humans through Computational Approach.
Rahman MM; Hossain MT; Reza MS; Peng Y; Feng S; Wei Y
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830241
[TBL] [Abstract][Full Text] [Related]
25. Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.
Drago-Ferrante R; Pentimalli F; Carlisi D; De Blasio A; Saliba C; Baldacchino S; Degaetano J; Debono J; Caruana-Dingli G; Grech G; Scerri C; Tesoriere G; Giordano A; Vento R; Di Fiore R
Oncotarget; 2017 Apr; 8(17):28939-28958. PubMed ID: 28423652
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
[TBL] [Abstract][Full Text] [Related]
27. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling.
Zheng S; Li M; Miao K; Xu H
J Cell Biochem; 2020 Mar; 121(3):2225-2235. PubMed ID: 31692053
[TBL] [Abstract][Full Text] [Related]
28. LncRNA SLC16A1-AS1 regulates the miR-182/PDCD4 axis and inhibits the triple-negative breast cancer cell cycle.
Jiang B; Liu Q; Gai J; Guan J; Li Q
Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):534-540. PubMed ID: 35316129
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD.
Luo D; Liang Y; Wang Y; Ye F; Jin Y; Li Y; Han D; Wang Z; Chen B; Zhao W; Wang L; Chen X; Jiang L; Yang Q
Breast Cancer Res; 2023 Sep; 25(1):109. PubMed ID: 37770991
[TBL] [Abstract][Full Text] [Related]
30. A Positive Feedback Loop Between TGFβ and Androgen Receptor Supports Triple-negative Breast Cancer Anoikis Resistance.
Rosas E; Roberts JT; O'Neill KI; Christenson JL; Williams MM; Hanamura T; Spoelstra NS; Vahrenkamp JM; Gertz J; Richer JK
Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33294922
[TBL] [Abstract][Full Text] [Related]
31. lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p.
Peng Y; Huang X; Wang H
BMC Mol Cell Biol; 2022 Jul; 23(1):34. PubMed ID: 35896973
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA ANRIL promotes carcinogenesis via sponging miR-199a in triple-negative breast cancer.
Xu ST; Xu JH; Zheng ZR; Zhao QQ; Zeng XS; Cheng SX; Liang YH; Hu QF
Biomed Pharmacother; 2017 Dec; 96():14-21. PubMed ID: 28961506
[TBL] [Abstract][Full Text] [Related]
33. LncRNA GATA3-AS1 facilitates tumour progression and immune escape in triple-negative breast cancer through destabilization of GATA3 but stabilization of PD-L1.
Zhang M; Wang N; Song P; Fu Y; Ren Y; Li Z; Wang J
Cell Prolif; 2020 Sep; 53(9):e12855. PubMed ID: 32687248
[TBL] [Abstract][Full Text] [Related]
34. MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54.
Liu B; Yao P; Xiao F; Guo J; Wu L; Yang Y
J Transl Med; 2021 Aug; 19(1):333. PubMed ID: 34353336
[TBL] [Abstract][Full Text] [Related]
35. LncRNA NEF is downregulated in triple negative breast cancer and correlated with poor prognosis.
Song X; Liu Z; Yu Z
Acta Biochim Biophys Sin (Shanghai); 2019 Apr; 51(4):386-392. PubMed ID: 30839051
[TBL] [Abstract][Full Text] [Related]
36. Identification of dysregulated miRNAs in triple negative breast cancer: A meta-analysis approach.
Naorem LD; Muthaiyan M; Venkatesan A
J Cell Physiol; 2019 Jul; 234(7):11768-11779. PubMed ID: 30488443
[TBL] [Abstract][Full Text] [Related]
37. Potentiation of cancerous progression by LISCH7 via direct stimulation of TGFB1 transcription in triple-negative breast cancer.
Tang X; Zhou Y; Liu Y; Zhang W; Liu C; Yan C
J Cell Biochem; 2020 Nov; 121(11):4642-4653. PubMed ID: 32048750
[TBL] [Abstract][Full Text] [Related]
38. lncRNA SEMA3B-AS1 Inhibits miR-513c-5p to Regulate the Progression of Triple-negative Breast Cancer.
Yu H; Wu Y; Huang J; Li S
Anticancer Res; 2023 Dec; 43(12):5475-5484. PubMed ID: 38030196
[TBL] [Abstract][Full Text] [Related]
39. The regulatory effect of 6-TG on lncRNA-miRNA-mRNA ceRNA network in triple-negative breast cancer cell line.
Zhang D; An X; Yu H; Li Z
Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33470407
[TBL] [Abstract][Full Text] [Related]
40. LncRNA MCM3AP-AS1 Downregulates LncRNA MEG3 in Triple Negative Breast Cancer to Inhibit the Proliferation of Cancer Cells.
Ren G; Han G; Song Z; Zang A; Liu B; Hu L; Jia L; Hong D; Yang L; Qie S
Crit Rev Eukaryot Gene Expr; 2021; 31(4):81-87. PubMed ID: 34587438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
